Clinical Trials Browser

Phase 2 × Prostate Cancer Metastatic × talazoparib × Clear all

NCT04824937 2021-04-01

Telaglenastat + Talazoparib In Prostate Cancer

Phase 2 Unknown

Prostate Cancer Metastatic